Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia - PubMed (original) (raw)

. 2020 Jun;31(6):1157-1165.

doi: 10.1681/ASN.2020030276. Epub 2020 Apr 28.

Zhiguo Zhang 2 3, Jing Peng 4, Liu Liu 1, Chunxiu Zhang 1, Chong Yu 1, Zufu Ma 5, Yi Huang 1, Wei Liu 1, Ying Yao 5, Rui Zeng 5, Gang Xu 1

Affiliations

Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia

Guangchang Pei et al. J Am Soc Nephrol. 2020 Jun.

Abstract

Background: Some patients with COVID-19 pneumonia also present with kidney injury, and autopsy findings of patients who died from the illness sometimes show renal damage. However, little is known about the clinical characteristics of kidney-related complications, including hematuria, proteinuria, and AKI.

Methods: In this retrospective, single-center study in China, we analyzed data from electronic medical records of 333 hospitalized patients with COVID-19 pneumonia, including information about clinical, laboratory, radiologic, and other characteristics, as well as information about renal outcomes.

Results: We found that 251 of the 333 patients (75.4%) had abnormal urine dipstick tests or AKI. Of 198 patients with renal involvement for the median duration of 12 days, 118 (59.6%) experienced remission of pneumonia during this period, and 111 of 162 (68.5%) patients experienced remission of proteinuria. Among 35 patients who developed AKI (with AKI identified by criteria expanded somewhat beyond the 2012 Kidney Disease: Improving Global Outcomes definition), 16 (45.7%) experienced complete recovery of kidney function. We suspect that most AKI cases were intrinsic AKI. Patients with renal involvement had higher overall mortality compared with those without renal involvement (28 of 251 [11.2%] versus one of 82 [1.2%], respectively). Stepwise multivariate binary logistic regression analyses showed that severity of pneumonia was the risk factor most commonly associated with lower odds of proteinuric or hematuric remission and recovery from AKI.

Conclusions: Renal abnormalities occurred in the majority of patients with COVID-19 pneumonia. Although proteinuria, hematuria, and AKI often resolved in such patients within 3 weeks after the onset of symptoms, renal complications in COVID-19 were associated with higher mortality.

Keywords: Acute Kidney Failure; COVID-19; Hematuria; Pneumonia; proteinuria.

Copyright © 2020 by the American Society of Nephrology.

PubMed Disclaimer

Figures

None

Graphical abstract

Similar articles

Cited by

References

    1. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. .: Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 382: 1199–1207, 2020. - PMC - PubMed
    1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. .; China Novel Coronavirus Investigating and Research Team: A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382: 727–733, 2020. - PMC - PubMed
    1. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. .: Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 395: 507–513, 2020. - PMC - PubMed
    1. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. .: Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China [published online ahead of print Feb 7, 2020]. JAMA 10.1001/jama.2020.1585 - DOI - PMC - PubMed
    1. Smith N, Fraser M: Straining the system: Novel coronavirus (COVID-19) and preparedness for concomitant disasters. Am J Public Health 110: 648–649, 2020. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources